Prenatal diagnosis of CLOVES syndrome confirmed by detection of a mosaic PIK3CA mutation in cultured amniocytes. Issue 10 (14th July 2014)

• Record Type: Journal Article
• Authors: Emrick, Lisa T.; Murphy, Lauren; Shamshirsaz, Alireza A.; Ruano, Rodrigo; Cassady, Christopher I.; Liu, Liu; Chang, Fengqi; Sutton, V. Reid; Li, Marilyn; Van den Veyver, Ignatia B.
• Is Part Of: American journal of medical genetics. Volume 164:Issue 10(2014.)
• Page Start: 2633
• Page End: 2637
• Publication Date: 2014-07-14
• Subjects: Medical genetics -- Periodicals; 616.14205
• DOI: 10.1002/ajmg.a.36672
• Languages: English
• ISSNs: 1552-4825

Abstract

<abstract abstract-type="main" xml:lang="en"> <title>ABSTRACT</title> <sec id="ajmga36672-sec-0001" sec-type="section"> <p>Congenital lipomatous asymmetric overgrowth of the trunk, lymphatic, capillary, venous, and combined‐type vascular malformations, epidermal nevi, skeletal and spinal anomalies (CLOVES) syndrome, a segmental overgrowth syndrome, is caused by post zygotic somatic mutations in <italic>PIK3CA</italic>, a gene involved in the receptor tyrosine kinase phosphatidylinositol 3‐kinase (PI3)‐AKT growth‐signaling pathway. Prenatal ultrasound findings of lymphovascular malformations, segmental overgrowth and skeletal defects can raise suspicion for CLOVES syndrome, but molecular confirmation of <italic>PIK3CA</italic> mutations on prenatally obtained samples is challenging because of somatic mosaicism. We detected a mosaic disease‐causing mutation in <italic>PIK3CA</italic> by sequencing of DNA extracted from cultured amniotic cells, but not from DNA directly prepared from an amniotic fluid sample in a fetus with prenatally suspected CLOVES syndrome. The infant was born prematurely and displayed severe lymphovascular malformations and segmental overgrowth consistent with a clinical diagnosis of CLOVES syndrome; he passed away at 29 days of life. We discuss the complexities and limitations of genetic testing for somatic mosaic mutations in the prenatal period and highlight the potential need for multiple approaches to arrive at a molecular diagnosis. © 2014 Wiley Periodicals, Inc.</p> </sec> </abstract>